Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population.

Chambliss, Allison B; Aljehani, Mayada; Tran, Brian; Chen, Xingyao; Elton, Elizabeth; Garri, Carolina; Ung, Nolan; Matasci, Naim; Gross, Mitchell E

Chambliss, Allison B; Aljehani, Mayada; Tran, Brian; Chen, Xingyao; Elton, Elizabeth; Garri, Carolina; Ung, Nolan; Matasci, Naim; Gross, Mitchell E.

Afiliação

Chambliss AB; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Aljehani M; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Tran B; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Chen X; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Elton E; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Garri C; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Ung N; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Matasci N; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.
Gross ME; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA, USA.

Pract Lab Med ; 36: e00323, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37649544

Palavras-chave

Antibodies; COVID-19; Chemokines; Cytokines; Immunology; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google